DNA-PK is a pattern recognition receptor (PRR) that binds cytosolic DNA and stimulates IRF3 signaling. Scutts et al. show that vaccinia virus antagonizes this DNA sensor with two proteins, C4 and C16, which both block DNA binding.
In Brief
DNA-PK is a pattern recognition receptor (PRR) that binds cytosolic DNA and stimulates IRF3 signaling. Scutts et al. show that vaccinia virus antagonizes this DNA sensor with two proteins, C4 and C16, which both block DNA binding.
INTRODUCTION
When confronted by a pathogen, the host's innate immune system is activated by pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) (Brubaker et al., 2015) . For viruses, the detection of viral nucleic acids is a critical element of this recognition (Luecke and Paludan, 2017; Pichlmair and Reis e Sousa, 2007) . There are several intracellular DNA sensors, such as DNA-dependent activator of interferon (IFN)-regulatory factor (DAI) (Takaoka et al., 2007) , absent in melanoma 2 (AIM2) (B€ urckst€ ummer et al., 2009; Dombrowski et al., 2011; Fernandes-Alnemri et al., 2009; Hornung et al., 2009; Roberts et al., 2009 ), RNA polymerase III Chiu et al., 2009 ), LRRFIP1 (Yang et al., 2010) , DExH-box helicase (DHX)9/DHX36 (Kim et al., 2010) , doublestrand break repair protein MRE11 (MRE11) (Kondo et al., 2013) , polyglutamine binding protein-1 (PQBP1) (Yoh et al., 2015) , gamma-IFN inducible protein 16 (IFI16) (Unterholzner et al., 2010) , cyclic guanosine monophosphate-AMP synthase (cGAS) (Sun et al., 2013) , and DNA-dependent protein kinase (DNA-PK) Zhang et al., 2011) . However, which DNA sensors detect specific viruses, whether these PRRs act independently or cooperatively, and their relative importance in vivo require further study.
Poxviruses have double-stranded DNA (dsDNA) genomes, yet they replicate within the cytoplasm. Poxviruses that cause human disease include monkeypox virus (Reynolds et al., 2004) , molluscum contagiosum virus (Hanson and Diven, 2003) and variola virus (VARV), the cause of smallpox, a disease eradicated by vaccination with vaccinia virus (VACV) (Fenner et al., 1988) . VACV is a useful expression vector (Mackett et al., 1982; Panicali and Paoletti, 1982) and has applications as vaccines against other pathogens (Panicali et al., 1983; Smith et al., 1983a Smith et al., , 1983b and as an oncolytic agent (Buller et al., 1985; Heo et al., 2013; Kirn and Thorne, 2009 ). In addition, interest in VACV endures because it is an excellent model to study hostpathogen interactions and cell biology .
The detection of DNA by PRRs triggers the production of type I IFN, cytokines, and chemokines (Stetson and Medzhitov, 2006 ) via a pathway that requires stimulator of IFN genes (STING) (Ishikawa et al., 2009) , TANK-binding kinase 1 (TBK1), and IFN regulatory factor 3 (IRF3) (Ishii et al., 2008 (Ishii et al., , 2006 Tanaka and Chen, 2012) . For example, the detection of VACV DNA induced IFN-b independently of Toll-like receptors (TLRs) and RNA polymerase III but was dependent on STING, TBK1, and IRF3 (Unterholzner et al., 2010) .
DNA-PK is a heterotrimeric complex consisting of the catalytic subunit DNA-PKcs and a heterodimer of Ku70 and Ku80. DNA-PK binds dsDNA breaks and functions in non-homologous end joining (NHEJ) (Pannunzio et al., 2018) and also in DNA sensing, upregulating type I IFN and cytokines via the STING pathway . The kinase activity of DNA-PKcs is essential for DNA repair (Kurimasa et al., 1999) but not for innate immune signaling. Cells and mice lacking DNA-PK components show impaired response to infection with VACV and herpes simplex virus 1 (HSV-1) . Ku70 also induces the expression of type III IFN in response to DNA (Sui et al., 2017; Zhang et al., 2011) .
The evolution of pathogens with their hosts has produced intriguing strategies for both host detection and pathogen subversion. VACV is a good example of this, and between one-third and one-half of its 200 proteins modulate the immune response (Bowie and Unterholzner, 2008; Elde et al., 2012; Gubser et al., 2004) . However, for dsDNA-binding PRRs, the only known direct inhibitor is protein VACV C16, an inhibitor of DNA-PK signaling . Mechanistically, the C-terminal region of C16 binds directly to the Ku heterodimer to block its binding to DNA. C16 also induces a hypoxic response by binding to PHD2 via its N-terminal domain and, in doing so, reprograms cellular energy metabolism (Mazzon et al., 2015) . In a murine intranasal (i.n.) model of infection, the VACV strain Western Reserve (WR) that lacks C16 caused an increase in infiltrating leukocytes, less weight loss with fewer signs of illness, and greater cytokine synthesis (Fahy et al., 2008; Peters et al., 2013) .
Here, another VACV protein, C4, is shown to target DNA-PK and inhibit DNA sensing. C4 shares sequence similarity to C16 and, like C16, binds to Ku to diminish DNA binding. This function mapped to the C-terminal domain of C4, and mutagenesis of three residues in both C4 and C16 abrogated binding to Ku. The infection of mice by viruses lacking C4 or C16 singly or together showed that these two proteins have both redundant and non-redundant functions. The loss of C4 increased recruitment and activation of cells involved in both innate and adaptive immunity. This phenotype is attributed to the suppression of cytokine production by C4 both in vitro and in vivo. Overall, this study identifies a second DNA-PK inhibitor encoded by a virus, adding to the evidence that DNA-PK is important to innate immunity. The complexity of host-pathogen interactions is highlighted by the finding that VACV encodes two multifunctional proteins that inhibit the same PRR to directly evade the detection of its genome, but, as yet, there are no reported inhibitors of other DNA sensors.
RESULTS

C4
Interacts with the Ku Heterodimer VACV proteins C4 and C16 share 54.4% identity in their C-terminal region of 150 amino acids (aa) ( Figure S1A ). Because this region of C16 binds the Ku heterodimer, we hypothesized that C4 might also share this function. Interestingly, C4 and C16 are conserved in orthopoxviruses, with some viruses encoding both proteins (VACV, cowpox virus [CPXV] , and VARV), whereas others encode only C16 (camelpox virus [CMLV] Figure S1B ), but all encode at least one.
To identify C4 binding partners, an inducible HEK293 TRex cell line was constructed that, upon addition of doxycycline, expresses C4 fused with Strep and FLAG tags (Gloeckner et al., 2007) , termed C4-TAP ( Figure S2 ). C4-TAP was purified by tandem affinity purification and analyzed by SDS-PAGE and silver staining. This revealed two proteins of 70 and 80 kDa that were more abundant than from uninduced cells ( Figure 1A ) and were confirmed as Ku70 and Ku80 by immunoblotting ( Figure 1B) . The third component of the DNA-PK complex DNA-PKcs did not bind to C4 ( Figure 1B) .
To examine if C4 binds Ku during infection and to test if C4 binds VACV proteins, HEK293T cells were infected with a VACV expressing TAP-tagged C4 (vC4-TAP) at the endogenous level (Ember et al., 2012) , and C4-TAP was purified as before. A VACV expressing TAP-tagged C6 (vC6-TAP) was used as a control (Maluquer de Motes et al., 2014) . As before, C4-TAP co-purified with Ku70 and Ku80 ( Figure 1C ) but not DNA-PKcs ( Figure 1D ). Immunoblotting for C16 showed that C16 did not associate with C4 ( Figure 1D ), indicating that C4 and C16 do not interact and that a Ku heterodimer does not bind C4 and C16 simultaneously to form a C4:Ku:C16 complex.
Immunoprecipitation of endogenous Ku70 ( Figure 1E ) and Ku80 ( Figure 1F ) from HEK293T cells infected with vC4-TAP or vC6-TAP confirmed that C4 interacts with the Ku heterodimer at endogenous levels during VACV infection.
C4 Blocks the Binding of Ku to DNA and Inhibits DNA Sensing To test if C4 affects binding of Ku to DNA, hemagglutinin (HA)-tagged C4 or C16 were expressed by transfection in HEK293T cells, and 24 hr later cells were transfected for 1 hr with biotinylated immunostimulatory DNA (ISD). The cytoplasmic DNA was then purified, and associated proteins were separated by SDS-PAGE. C4 was absent, confirming that C4 does not bind DNA (Figure 2A) . However, the level of Ku70 precipitated by DNA was reduced by C4. Quantification showed that C4 significantly reduced Ku-DNA binding to levels similar to that of C16 ( Figure 2B ).
Because DNA-PK is a DNA sensor, the ability of C4 to alter IRF3 activation was tested by immunoblotting for phosphorylated IRF3 (P-IRF3) after transfection with ISD in HeLa cells. C4 reduced P-IRF3 levels ( Figure 2C ), and this was quantified by normalization to a-tubulin ( Figure 2D ). ELISAs showed that mouse embryonic fibroblasts (MEFs) co-transfected with ISD and a plasmid expressing C4 produced less interleukin-6 (IL-6) ( Figure 2E ) and C-X-C motif chemokine 10 (CXCL10) (Figure 2F ) compared with cells transfected with an empty vector (EV), but no reduction was observed in response to the double-stranded RNA (dsRNA) analog poly (I:C) ( Figures 2E and  2F ). In addition, a pcDNA plasmid was digested with BamHI and NotI to produce dsDNA breaks that could be recognized by DNA-PK. C4 also reduced production of CXCL10 in response to this stimulus ( Figure 2G ). MEFs lacking DNA-PK produce much lower levels of cytokines and chemokines in response to ISD . To confirm that the antagonism of DNA sensing by C4 was dependent on DNA-PK, a CXCL10 ELISA was performed with DNA-PKcs null cells (Prkdc À/À MEFs). Stimulation with ISD resulted in a low level of CXCL10 production, as expected, and this was unaffected by C4 ( Figure 2H ).
Overall, these data demonstrate that C4 inhibits DNA sensing but not RNA sensing and reduces the synthesis of cytokines and chemokines. Mechanistically, C4 binds to the Ku heterodimer and diminishes its ability to bind DNA in the cytoplasm, antagonizing activation of the IRF3 pathway.
Inhibition of Ku Is Mediated by the C-Terminal Region of C4
To identify the region of C4 needed to bind Ku, TAP-tagged truncation mutants of C4 ( Figure 3A) were expressed in HEK293T cells, and their ability to bind to Ku was assessed. The C-terminal fragments 157-331 and 167-331 co-immunoprecipitated with Ku70, but further truncation (177-331 and 187-331) caused a loss of binding ( Figure 3B ). This suggested that residues between 167 and 176 are needed for the interaction. The fragments 1-206 and 1-156 were unable to bind, and because the 1-206 fragment (A) DNA affinity purification. HEK293T cells were transfected with 2 mg/ml of EV or plasmids encoding HA-tagged C4 or C16 for 24 hr, followed by 7.5 mg/ml of 45-base pair (bp) biotinylated immunostimulatory DNA (ISD) for 1 hr. Cells were lysed, and streptavidin beads were incubated with cytoplasmic fractions to purify the biotinylated DNA and associated proteins. Samples were analyzed by SDS-PAGE and immunoblotting with Ku70 and HA antibodies.
(B) Integrated intensity of Ku70 AP from (A) from three experimental replicates was calculated by infrared imaging by using a Li-Cor Odyssey scanner.
(C) P-IRF3 immunoblotting. HeLa cells were transfected for 24 hr with EV or C4-TAP plasmid and then stimulated by transfection with 7.5 mg/ml of 180-bp ISD at the time point indicated. Whole cell lysates were analyzed by immunoblotting with antibodies against the indicated proteins.
(D) Integrated intensity of P-IRF3 from (C) was normalized to corresponding a-tubulin levels from three experimental replicates by using a Li-Cor Odyssey scanner.
(E and F) MEFs were mock transfected (NS), transfected with 80 ng/ml EV or plasmids encoding TAP-tagged C4 or C16, and cotransfected with 750 ng/ml ISD or 100 ng/ml poly (I:C) for 24 hr. Levels of (E) IL-6 and (F) CXCL10 in supernatants were measured by ELISA, performed in quadruplicate.
(G) MEFs were mock transfected (NS), transfected with 80 ng/ml EV or plasmids encoding TAP-tagged C4 or C16, and cotransfected with 750 ng/ml EV pcDNA4/TO linearized previously with BamHI and NotI. After 24 hr, levels of CXCL10 in supernatants were measured by ELISA in quadruplicate.
(legend continued on next page)
contains residues 167-176, this shows that this ten-residue region is necessary but not sufficient for the interaction ( Figure 3B) . These mutants were then tested for inhibition of CXCL10 and IL-6 production. In MEFs, 167-316, which binds Ku, reduced levels of IL-6 and CXCL10 in response to ISD, whereas 177-316, which does not bind Ku, did not ( Figures 3C and 3D ). This shows that the C-terminal domain of C4 causes an inhibition of the DNA-PKmediated DNA sensing and that it is dependent on binding to Ku.
Site-Directed Mutagenesis of C4 and C16 Abrogates Binding to Ku
Because residues needed to bind Ku might lie between C4 residues 167 and 176, these residues from different orthologs were compared with the corresponding residues in C16 ( Figure 4A ). Residues C174, Y175, and C176 were conserved in all C4 orthologs and also in C16 (C16 residues C187, Y188, and C189).
The CYC motif was then mutated, and the binding of these mutants was assessed. Substitution of either cysteine residue to alanine did not reduce the amount of co-precipitated Ku; however, a Y175A mutation decreased binding, suggesting that the tyrosine was important for the interaction ( Figure 4B ). Further mutation with double and triple alanine substitutions showed that only CYC to AAA fully abrogated binding to Ku, demonstrating that each residue plays a role in the interaction (Figure 4B) . Notably, the expression of the mutants was reduced, indicating that these residues are important for stability. To ensure that the lack of binding was not due to less prey protein, the dose of wild-type (WT) C4 plasmid was reduced to obtain similar levels as the C4 AAA mutant. Immunoprecipitation showed that WT C4 bound to Ku70 and C4 AAA did not, confirming that mutagenesis abrogated binding ( Figure 4C ).
Substitution of tyrosine by phenylalanine (AFA) retained binding to Ku, indicating that the aromatic ring is important for binding ( Figure 4D ). Consistent with this, the mutants AFC, CFA, and CFC all co-precipitated similar levels of Ku as those of WT C4 ( Figure 4D ). Given that these residues are conserved in C16, (H) Prkdc À/À MEFs were mock transfected (NS), transfected with 80 ng/ml EV or TAP-tagged C4 plasmid, and cotransfected with 750 ng/ml ISD or 100 ng/ml poly (I:C) for 24 hr. Levels of CXCL10 in supernatants were measured by ELISA, performed in quadruplicate. Data are represented as ±SD. **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. = non-significant. Each experiment was performed three times and one representative experiment is shown. (C and D) MEFs were mock transfected (NS), transfected with 80 ng/ml EV or plasmids encoding TAP-tagged full-length C4 or C4 amino acid residues 167-316 or 177-316, and cotransfected with 750 ng/ml ISD. After 24 hr, levels of (C) IL-6 and (D) CXCL10 in supernatants were measured by ELISA. Data are represented as ±SD. **p < 0.01, ***p < 0.001, n.s. = non-significant. Each experiment was performed three times and one representative experiment is shown.
the CYC residues of C16 were mutated to AAA and AFA. The C16 AAA mutant did not bind Ku, whereas AFA did. This demonstrated that these residues are important for binding Ku in both C4 and C16 and that the tyrosine aromatic ring is critical for the C16 interaction ( Figure 4E ). Importantly, the C16 mutants were stable, and immunoblotting with an anti-prolyl hydroxylase domain-containing protein 2 (PHD2) antibody showed that they still bound to PHD2, another C16 binding partner.
Collectively, these data show that CYC residues are conserved in C4 and C16, are essential for Ku binding, and that the phenyl ring of the tyrosine residue forms the crux of this interaction.
Deletion of Both C4 and C16 Causes Attenuation of Virus Virulence Previously, the virulence of a virus lacking C4 (vDC4) was tested in two murine models of infection (Ember et al., 2012) . In the i.n. (A) Amino acid residues CYC are conserved between C4 (C174, Y175, and C176) and C16 (C187, Y188, and C189). Protein sequence alignment of C4 residues 167-177 from VACV strain WR and corresponding residues of C16 and other C4 orthologs of various orthopoxviruses. Black shading represents the sequence others are aligned to. Red and yellow shading indicates identical and highly similar residues, respectively. GenBank accession numbers: VACV-WR C16, YP_232892.1; VACV-WR C4L, YP_232906.1; VACV-Lister 021, ABD52470.1; VACV-COP C4L, AAA47996.1; CPXV-BR 033, NP_619822.1; CPXV-GRI 030, CAA64101.1; RBPX-UTR 016, AAS49729.1; VARV-IND3 011, NP_042055.1; VARV-GAR B17L, CAB54611.1; CMLV-CMS 22L, AAG37478.1; MPXV-ZAR D13L, NP_536443.1; and TATV 025, YP_717332.1. (B) Mutagenesis of C4 residues CYC alters binding to Ku. TAP-tagged wild-type C4 (CYC) and C4 mutants as indicated were expressed in HEK293T cells and immunoprecipitated with anti-FLAG agarose beads. Proteins were separated by SDS-PAGE and analyzed by immunoblotting with anti-Ku70 and imaged with high and low intensity, anti-FLAG, and anti-C4 antibodies. (C) Mutagenesis of CYC to AAA abrogates binding to Ku. Different quantities of wild-type C4 plasmid were transfected into HEK293T cells to obtain comparable expression with the C4 AAA mutant, and then lysates were subjected to immunoprecipitation with anti-FLAG agarose beads and analyzed by immunoblotting. (D and E) The aromatic ring of tyrosine in CYC of (D) C4 and (E) C16 is a critical component of this interaction. Plasmids encoding indicated TAP-tagged proteins were transfected into HEK293T cells and protein complexes were immunoprecipitated with anti-FLAG agarose beads. Immunoblotting was performed with the indicated antibodies. Immunoblots are representative of three independent experiments. model, the virus replicates in the lungs before spreading to other organs (Alcamí and Smith, 1992; Tscharke and Smith, 1999) , whereas, in the intradermal (i.d.) model, infection of the ear pinna causes a localized lesion Tscharke and Smith, 1999) . Mice inoculated i.d. with vDC4 had no change in lesion size compared to control viruses. In contrast, i.n. infection with vDC4 induced less weight loss and milder signs of illness compared to controls (Ember et al., 2012) . Similarly, a virus lacking C16 (vDC16) had reduced virulence in the i.n. model but not in the i.d. model (Fahy et al., 2008) . Both C4 and C16 are nonessential for virus replication in vitro (Ember et al., 2012; Fahy et al., 2008) . To test if the loss of both genes altered virulence, a recombinant virus lacking both genes (vDC16,DC4) was constructed using vDC16 as the parental virus ( Figure S3 ). C4 was then inserted back into vDC16,DC4 as a revertant control (vDC16-Rev).
Plaques formed by vDC16,DC4 were significantly smaller than those formed by viruses lacking only C16 ( Figure S4A ). To test if this was due to reduced virus production or reduced spread, virus replication was examined after infection at low (0.01) or high (10) MOI. The production of intracellular mature virus (IMV) (Figures S4B and S4D ) and extracellular enveloped virus (EEV) ( Figures S4C and S4E ) by vDC16,DC4 were unaltered from control viruses, showing that the reduction in plaque size was not due to reduced replication but might be due to the effects of C4 on antiviral innate immune responses.
Skin lesions caused by i.d. infection with vDC16,DC4 were significantly smaller from days 6 to 15 p.i. and healed sooner than those caused by viruses lacking only C16 ( Figure 5A ). This result indicates that C4 and C16 share redundancy in this model because the single deletion viruses had WT virulence. This may be due to the suppression of DNA-PK-mediated DNA sensing because this is the only known shared function. Following i.n. infection, animals lost weight after 3 days p.i. irrespective of the virus. However, mice infected with vDC16,DC4 lost less weight from 5 to 11 days p.i. (Figure 5B ), showed fewer signs of illness from day 7 onward (Figure 5C ), and recovered faster compared to mice infected with viruses lacking only C16 (vDC16 and vDC16-Rev). This indicates that C4 functions in the absence of C16 and, therefore, does not require C16 for co-operativity. Measurements of viral titers revealed no difference at 2 days p.i., slightly lower titers at 5 days p.i., and significantly lower virus titers at 8 days p.i. in mice infected with vDC16DC4 compared to control viruses ( Figure 5D ). This indicates better virus clearance at later time points. These data are consistent with C4 inhibiting the antiviral response in vivo. lungs of infected mice were extracted and analyzed by flow cytometry. Gating strategies are displayed in Figure S5 . In the BAL fluid at day 5 p.i., vDC16,DC4 gave a significantly higher number of macrophages compared to vDC16 and vDC16-Rev ( Figures  6A and 6B ). At day 8 p.i., neutrophil levels had significantly decreased, indicating that the inflammatory response in these mice had begun to subside. In the lungs, a greater number of natural killer (NK) cells were found at 2 and 5 days p.i. compared to control viruses ( Figure 6C ). To study the adaptive immune response, lung homogenates were stained for CD19 to assess the numbers of B cells and CD3, CD4, CD8, and CD69 to assess the recruitment and activation of T cells. No significant difference in the number of B cells was observed ( Figure 6D) ; however, the number and activation status of CD4 + and CD8 + T cells was increased at 2 and 5 days p.i. compared to control viruses (Figures 6E-6H) .
The mechanism underlying the effects of C4 on virulence and immune cell recruitment in vivo was then studied by measuring the levels of cytokines and chemokines in BAL fluids after i.n. infection with vDC16,DC4 versus vDC16 and vDC16-Rev. Infection induced the production of IL-6 and CXCL-10, which both increased with time ( Figures 6I and 6J ). The deletion of C4 from vDC16 resulted in enhanced secretion of these cytokines, particularly for IL-6, and is consistent with the impact of C4 on production of these inflammatory molecules in vitro. This was significant at 48 and 72 hr p.i. for IL-6 (p < 0.0001) ( Figure 6I ) and 48 hr for CXCL10 (p < 0.01) ( Figure 6J ).
Deletion of C4 from WT WR VACV also Results in Increased Recruitment of Innate Immune Cells and Activation of T Cells
The fact that deleting C4 from a WT VACV WR strain (that expresses C16) reduces virulence (Ember et al., 2012) shows that C4 contains non-redundant function(s) that contribute to virulence. C4 inhibits nuclear factor kB (NF-kB) signaling by an unknown mechanism (Ember et al., 2012) , and this is a potential explanation, or C4 may have some other function(s). To study the effects of these non-redundant function(s) of C4 on the cellular inflammatory response, cells from BAL fluids and lungs of mice infected with vDC4 and control viruses were analyzed by flow cytometry. The total number of viable cells in BAL fluid was significantly increased at 5 days p.i. with infection of vDC4 compared to WT (Ember et al., 2012) , and here, we examined whether this was due to any particular lymphoid subsets.
More macrophages and neutrophils in the BAL fluid and NK cells in the lungs were detected as early as 2 days p.i. (Figures  7A-7C ). Greater increases in numbers for macrophages and neutrophils were seen at 5 days p.i. However, by day 8, neutrophil levels had decreased, indicating that the inflammatory response had begun to subside. To study the adaptive immune response, lung homogenates were stained for CD19 to assess the numbers of B cells and CD3, CD4, CD8, and CD69 to assess the recruitment and activation of T cells. No significant difference in the number of B cells was observed ( Figure 7D ). Although there were no statistically significant differences in the total number of CD4 + and CD8 + T cells, a measurement of their activation status indicated that more of these cell types displayed an activated phenotype (CD69 + ) by 5 days p.i. in the lungs of vDC4-infected mice compared to control infections ( Figures 7E-7H ). Taken together, these data demonstrate that there are more innate immune cells and activated T cells in the lungs of mice infected with viruses lacking only C4, despite the presence of C16.
DISCUSSION
During infection, cytoplasmic DNA activates innate immune signaling that restricts virus replication and stimulates adaptive immunity. VACV produces cytoplasmic viral factories containing large amounts of virus DNA, and thus, evading recognition by cytosolic PRRs is beneficial to VACV. Here, we report that VACV protein C4 acts as another inhibitor of DNA-PK, emphasizing the biological role of DNA-PK as a DNA sensor. An interaction between C4 and Ku occurs at endogenous levels and blocks the binding of Ku to DNA to prevent the activation of IRF3 and the production of proinflammatory molecules. The mutagenesis of C4 showed that the C-terminal domain was needed for binding Ku and residues C174, Y175, and C176 are critical for this. Understanding the structural basis of this interaction will be valuable in the future. C4 is related to another VACV protein, C16, and the C-terminal domain of C16 also inhibits DNA-PK-mediated DNA sensing via the same mechanism and to a similar level as C4. Moreover, mutagenesis of C16 at the CYC residues equivalent to those in C4 abrogated the C16-Ku interaction, indicating that C4 and C16 bind to Ku in a similar manner. A summary of the C4 and C16 functional domains is shown in Figure S6 .
In vivo, C4 and C16 are non-redundant in that deletion of either caused reduced virulence after i.n. infection (Ember et al., 2012; Fahy et al., 2008) , and a double deletion virus was attenuated further. In contrast, redundancy was observed in the i.d. model because deletion of either C16 or C4 alone did not affect virulence (Ember et al., 2012) , but double deletion reduced virulence. This may be due to the common inhibition of DNA-PK, and the lack of redundancy in the i.n. model is likely due to other functions of these proteins ( Figure S6 ). Indeed, C16 also induces a hypoxic response , reprogramming the central energy metabolism (Mazzon et al., 2015) , and C4 inhibits NF-kB signaling (Ember et al., 2012) , and other unknown functions may exist. The response to infection with vDC16DC4 showed that C4 inhibits the recruitment of macrophages, neutrophils, and NK cells, and reduces the recruitment and activation of CD4 + and CD8 + T cells. C4 also inhibits the secretion of IL-6 and CXCL10 in vivo, and this may explain the changes in infiltrating leukocytes. Similar analyses with viruses expressing C4 and C16 with point mutations that abrogate each of their functions alone would be interesting. This was attempted for the C4 AAA mutant; however, expression of C4 AAA by the virus was too low to justify in vivo infection (data not shown). It is remarkable that VACV proteins C4 and C16 perform the same function by the same mechanism. This might be explained by C4 and C16 having other functions that are enhanced by binding Ku, or redundancy might enable each protein to carry out other functions better. Alternatively, one protein alone might be insufficient to inhibit DNA-PK, particularly early in infection, given that DNA-PK is a very abundant complex. Both C4 and C16 are made early p.i. with nucleocytoplasmic localizations (Ember et al., 2012; Fahy et al., 2008) ; however, slight differences in (I and J) At the indicated times p.i., mice were killed and BAL fluid was extracted, and levels of (I) IL-6 and (J) CXCL10 were measured by ELISA (n = 5). Data are represented as means of cell counts ± SD. *p < 0.05 and **p < 0.01 for vDC16/DC4, compared with both vDC16 and vDC16/C4-Rev. Each experiment was performed twice and one representative experiment is shown.
expression levels and localization might exist. Having two proteins may also be beneficial should the host act to prevent either protein from functioning. Finally, because VACV has a broad host range, variations in Ku proteins in different hosts may require slightly different viral proteins to ensure functional binding. Interestingly, VACV was shown recently to also inhibit STING activation in a C16-independent manner by an alternative mechanism, acting at or downstream of cGAMP (Georgana et al., 2018) . The expression of multiple inhibitors of a single pathway is common in pathogen evasion. For example, >10 VACV proteins inhibit NF-kB activation (Bowie et al., 2000; Chen et al., 2008; Cooray et al., 2007; DiPerna et al., 2004; Ember et al., 2012; Gedey et al., 2006; Mansur et al., 2013; Myskiw et al., 2009; Schrö der et al., 2008; Shisler and Jin, 2004; Stack et al., 2005) , and these proteins are not redundant in vivo because, where tested, deletion of each one alone attenuates virulence (Bartlett et al., 2002; Benfield et al., 2013; Brandt and Jacobs, 2001; Chen et al., 2006; Ember et al., 2012; Harte et al., 2003; Mansur et al., 2013; Stack et al., 2005) . C4 and C16 are also not the only example of VACV proteins that perform the same function via the same mechanism. The VACV enzymes D9 and D10 share $25% sequence identity and both decap host and viral mRNAs . This prevents an accumulation of dsRNAs to reduce the anti-viral response to this PAMP (Liu et al., 2015) . Redundancy was found as WT virus and D9 or D10 catalytic site mutants retained virulence during i.n. infection, but a double mutant was attenuated (Liu et al., 2015) . This is similar to viruses lacking C4, C16, or both proteins in the i.d. model. cGAS has a central role in STING activation after DNA sensing, but it is unknown if most of the DNA sensors act independently or Data are represented as means of cell counts ± SD. *p < 0.05 and **p < 0.01 for vDC4, compared with both vC4 and vC4-Rev. Each experiment was performed twice and one representative experiment is shown.
in cooperation with the cGAS-cGAMP pathway. This was addressed for IFI16 (Almine et al., 2017; Jønsson et al., 2017) and PQBP1 (Yoh et al., 2015 ) but remains to be tested for DNA-PK. Individual DNA sensors may share redundancy with each other but may be important for responding to specific types of DNA while avoiding self DNA. DNA-PK acts in a larger complex containing HEXIM1, NEAT1 long non-coding RNA, cGAS, and paraspeckle components (splicing factor, proline-and glutamine-rich (Morchikh et al., 2017) . Upon stimulation of cells with ISD, DNA-PKcs was phosphorylated, paraspeckle proteins were released, STING was recruited, and IRF3 was activated, in a HEXIM1-dependent manner. The assembly of the complex, the precise function of each subunit, and whether they influence cGAS enzymatic activity are unknown. C4 and C16, being specific inhibitors, may be useful tools to investigate the role of DNA-PK. DNA-PK can detect viruses other than VACV, including hepatitis B virus (Li et al., 2016) , HSV-2 (Sui et al., 2017) , and human T lymphotropic virus type 1 (Wang et al., 2017) . Whether DNA-PK can sense other viruses and bacteria remains to be tested, and this testing should include nuclear DNA pathogens because DNA-PK is predominately nuclear. Other pathogens may have proteins to evade this receptor, yet VACV C4 and C16 are the only ones identified to date. This paper describes the second DNA sensor inhibitor expressed by VACV, and, similar to the first, it targets DNA-PK to block DNA binding. Interestingly, VACV has evolved two proteins that inhibit DNA-PK; however, it is not known to encode proteins that directly inhibit any of the other reported DNA sensors. This emphasizes the importance of DNA-PK as a PRR. Learning more about the C4 and C16 interactions with Ku may allow for the development of small molecule inhibitors that mimic this interaction. This would be relevant to human autoimmune diseases associated with dysregulated DNA sensing, for example AicardiGoutiè res (Ahn and Barber, 2014) . Our work on the viral inhibitors C4 and C16, along with similar studies, contributes to the understanding of the complex initial stages of DNA detection and the interplay between the DNA damage response and inflammation.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
DECLARATION OF INTERESTS
The authors declare no competing interests. 
CONTACT FOR REAGENTS AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Geoffrey L. Smith (gls37@cam.ac.uk) .
EXPERIMENTAL MODEL AND SUBJECT DETAILS Viruses
The recombinant VACV Western Reserve strain C6-TAP, C4-TAP, vC4, vDC4, and vC4-Rev viruses were described (Maluquer de Motes et al., 2014) and (Ember et al., 2012) . Recombinant viruses were constructed using a transient dominant selection method (Falkner and Moss, 1990) in the same manner as for construction of vDC4 and vC4-Rev as described (Ember et al., 2012) but initiated by transfecting Z11DC4 into vDC16-infected cells (to make vDC16DC4) or Z11C4Rev into vDC16DC4-infected cells (to make vDC16-Rev). The viruses were genotyped using PCR and primers amplifying the flanking regions of the C4L and C16L genes.
Cell Lines BSC-1 (ATCC CCL-26) and HEK293T (ATCC CRL-11268) cells were maintained in DMEM containing 10% fetal bovine serum (FBS) and penicillin-streptomycin (50 mg/ml; PS). RK-13 (ATCC CCL-37) cells were maintained in minimum essential medium (MEM), supplemented as above. HeLa (ATCC CCL-2) cells were cultured in MEM, supplemented above with the addition of 1% nonessential amino acids. MEFs (Xrcc5 ) were grown in DMEM containing 15% FBS and PS. HEK293 TRex cells (Life Technologies) were grown in DMEM supplemented with 15% (v/v) FBS, PS, blasticidin (50 m g/ml), and zeocin (100 m g/ml).
Mice
Female BALB/c and C57BL/6 mice were handled as previously described (Alcamí and Smith, 1992; Williamson et al., 1990) . This work was performed according to regulations of The Animals (Scientific Procedures) Act 1986. All procedures were carried out under the home office project licenses PPL 70/7116 and PPL 70/8524, as approved by the United Kingdom Home Office.
METHOD DETAILS Plasmids
Codon-optimized C4-TAP and C16-TAP plasmids were described previously (Ember et al., 2012; Peters et al., 2013) . Site-directed mutagenesis of C4 and C16 was performed by amplifying from above plasmids and by using an overlapping PCR method as Table S1 . This paper N/A Primers for constructing C4 mutant plasmids, see Table S1 . This paper N/A Primers for PCR analysis of recombinant VACV genomes, see Table S1 .
This paper N/A Other Sanger sequencing Source Bioscience https://www.sourcebioscience.com/ described in Higuchi et al. (1988) and oligonucleotide primers designed to contain the desired change and approximately 20 nucleotides 5 0 and 3 0 to the mutation site that were complementary to the template plasmid. PCR products for C4 truncation mutants were produced by amplification from the C4-TAP plasmid. All PCR products were cloned into the mammalian expression vector pcDNA4/TO (Invitrogen) with a C-terminal TAP tag. pcDNA4/TO was used in ELISAs and affinity purifications as EV. Plasmids used for construction of vDC16DC4 and vDC16-Rev were described previously (Ember et al., 2012) . 
Transfection of Cell Lines
Viruses
The recombinant VACV Western Reserve strain C6-TAP, C4-TAP, vC4, vDC4, and vC4-Rev viruses were described (Maluquer de Motes et al., 2014; Ember et al., 2012) . Recombinant viruses were constructed using a transient dominant selection method (Falkner and Moss, 1990) in the same manner as for construction of vDC4 and vC4-Rev as described (Ember et al., 2012) but initiated by transfecting Z11DC4 into vDC16-infected cells (to make vDC16DC4) or Z11C4Rev into vDC16DC4-infected cells (to make vDC16-Rev). The viruses were genotyped using PCR and primers amplifying the flanking regions of the C4L and C16L genes. Immunoprecipitation and Affinity Purification HEK293T cells were seeded in 10-cm dishes and transfected the next day with pcDNA4/TO plasmids for 24 hr. Then, cells were washed once with PBS and lysed in immunoprecipitation (IP) lysis buffer (0.5% NP-40, PBS) supplemented with cOmplete Mini EDTA-free protease inhibitor cocktail (Roche). Insoluble material was collected by centrifugation at 21,000 3 g for 15 min at 4 C and discarded. For anti-FLAG immunoprecipitations, lysates were incubated with FLAG M2 agarose beads (Sigma-Aldrich). For anti-streptavidin affinity purifications, lysates were incubated with streptavidin agarose (Thermo Scientific). For anti-Ku70 and anti-Ku80 immunoprecipitations, lysates were incubated with 2.5 mg of Ku70 antibody (Abcam, ab3114) or Ku80 antibody (Santa Cruz, sc-1484) and protein G-conjugated FastFlow Sepharose beads (GE Healthcare). Immunoprecipitations were incubated on a rotator overnight at 4 C and then washed four times with IP lysis buffer. Proteins were eluted by resuspension in Laemmli SDS-PAGE loading buffer and incubated at 95 C for 5 min.
Tandem Affinity Protein Purification
The C4-TAP HEK293 TRex cell line was induced with 2 mg/ml doxycycline overnight or uninduced, or HEK293T cells were infected with vC4-TAP or vC6-TAP at 2 PFU/cell overnight. Tandem affinity purification of C4-TAP and C6-TAP was carried out as described in Gloeckner et al. (2007) with FLAG M2 agarose beads (Sigma-Aldrich) and Strep-Tactin superflow beads (IBA). Protein complexes were separated by SDS-PAGE, and bands were visualized by silver staining.
DNA Affinity Purification Double-stranded immunostimulatory DNA (sense sequence, TACAGATCTACTAGTGATCTATGACTGATCTGTACATGATCTACA) was biotinylated at its 3 0 end and transfected into HEK293T cells at 7.5 mg/ml for 1 hr. Cells were lysed with virus overlay protein binding assay (VOPBA) buffer (100 mM Tris-Cl, pH 8, 0.2% Triton X-100, 2 mM MgCl 2 , 1 mM EDTA), followed by centrifugation at 600 3 g for 3 min at 4 C. The supernatant was subjected to centrifugation at 21,000 3 g for 10 min at 4 C, and the pellet was discarded to obtain the final crude cytoplasmic fraction. Anti-streptavidin agarose (Thermo Scientific) was used to purify biotinylated DNA and the associated proteins. Immunoblotting Proteins in cell lysates were separated by electrophoresis and transferred to a nitrocellulose Amersham Protran membrane (GE Healthcare). The membrane was blocked for 1 hr in 5% milk in PBS containing 0.1% Tween-20 at 23 C. Then, the membrane was incubated with primary antibody (Ab) diluted in blocking buffer at 4 C overnight. Antibodies used were from the following sources: DNA-PKcs (NeoMarkers, MS-423-P1, diluted 1:1000), Ku70 (AbCam, ab3114, diluted 1:1000), Ku80 (Santa Cruz, sc-1484, 1:500), FLAG (Sigma-Aldrich, F7425, diluted 1:5000), HA (Sigma-Aldrich, H6908, diluted 1:1000), P-IRF3 (Abcam, ab76493, diluted 1:1500), and a-tubulin (Merck Millipore, 05-829, diluted 1:10000). Membranes were probed and visualized with LI-COR Biosciences secondary Abs and the Li-Cor Odyssey infrared imaging system according to the manufacturer's instructions. A quantification of protein bands was performed, where indicated, by using Odyssey software (LI-COR Biosciences).
Analysis of Plaque Size
The diameters of 30 plaques per virus were measured using Axiovision 4.6 on a Zeiss Axiovert 200 M microscope (Zeiss).
Analysis of Virus Growth Kinetics
Monolayers of BSC-1 cells were infected with either 10 or 0.01 PFU per cell with recombinant viruses for measurement of single-step or multi-step growth kinetics, respectively. After 1.5 hr of virus attachment and entry into cells, the infection medium was aspirated, the cells were washed with fresh medium, and then the flasks were returned to the incubator. At the indicated times post-infection, the medium was removed and cells were collected by centrifugation at 500 3 g for 10 min. The supernatant was collected and titrated immediately on BSC-1 cells. The cells still attached to the flask were scraped into 3 ml of fresh medium and added to the pellet from the first centrifugation step. The cells were collected by centrifugation as above, resuspended into 500 mL infection medium and stored at À20 C until titration on BSC-1 cells.
Murine i.n. and i.d. Models of Infection All viruses used for in vivo work were purified by sedimentation twice through a sucrose cushion prior to inoculation. For i.n. infection, groups of five female BALB/c mice (6-8 weeks old) were anaesthetized and inoculated with 1 3 10 5 PFU into both nostrils. Weight loss was measured and signs of illness were scored (hair ruffling, pneumonia, back arching, and decreased mobility) daily (Alcamí and Smith, 1992; Williamson et al., 1990) . For the i.d. model of infection, groups of five female C57BL/6 mice (6-8 weeks old) were infected with 10 4 PFU in both ear pinna, and a micrometer was used to measure lesion diameter.
BAL fluids were harvested on the indicated days by flushing lungs with 1 ml of PBS containing 10 U/ml heparin and centrifuged at 500 3 g. The pellet contained cells used for flow cytometry, and the supernatant was used for ELISA. The number of live cells in BAL fluids was quantified using a hemocytometer and trypan blue staining.
For extraction from lung, the lung tissue was cut into small pieces and incubated in 3 ml digestion buffer (RPMI-10 + 1 mg/ml collagenase + 30 mg/ml DNaseI), and then the lung homogenate was filtered through a cell strainer and 250 ml was collected for virus titration. The remainder of the lung homogenate was centrifuged at 500 3 g to collect the cells. The cells were then resuspended in ACK buffer (150 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM Na 2 EDTA, pH 7.4) and incubated at 23 C for 3 min. Nineteen milliliters of RPMI-10 buffer was added, and the cells were collected as before by centrifugation. The cells were then resuspended in 20% Percoll (Sigma) in RPMI-10 and were centrifuged at 1000 3 g for 20 min. Finally, the cells were resuspended in 1 ml FACS buffer (0.1% [w/v] BSA, 0.1% [w/v] NaN 3 in PBS, pH 7.4) and enumerated by trypan blue exclusion.
Cell Staining and Flow Cytometry CD3 (clone 145-2C11), CD4 (GK1.5), CD8 (5H10-1), CD45R (RA-6B2), NK1.1 (PK136), CD69 (H1.2F3), Ly6G (1A8), and CD16/32 (2.4G2) antibodies were purchased from BD Biosciences, and F4/80 (BM8) antibody was purchased from BioLegend. These antibodies were purified or conjugated with PerCP/cy5.5, fluorescein isothiocyanate (FITC), APC/Cy7, APC, PE-Cy7, PE, or BV650. Relevant isotype controls were used as described elsewhere . Stained cells were measured by flow cytometry on a BD FACS CantoII flow cytometer, and these data were analyzed using Summit software (Beckman Coulter).
ELISA CXCL10 and IL-6 levels in cell supernatants were measured with DuoSet ELISA kits (R&D Systems) in accordance with the manufacturer's protocol.
Bioinformatic Analyses
Clustal Omega was used to perform sequence alignments, and these were manually curated using GeneDoc.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed by unpaired Student's t tests by using GraphPad Prism 5 software. Quantification of immunoblot signal intensities was performed using a Li-Cor Odyssey infrared imaging system (LI-COR Biosciences) and Odyssey software (LI-COR Biosciences). Statistical details for individual experiments can be found in the figure legends. Experiments performed with cells in vitro were carried out at least three times, and in vivo mouse experiments were performed twice. One representative of each experiment is shown. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. = non-significant.
